Bioequivalence Study of Two Oral Haloperidol Tablets Formulations in Healthy Subjects Under Fasting Conditions

NCT04411940 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

32

Enrollment

INDUSTRY

Sponsor class

Conditions

Bioequivalence

Interventions

DRUG: Haloperidol Tablets, Mylan Pharmaceuticals Inc.
DRUG: Haloperidol Tablets, Cycle Pharmaceuticals Ltd

Sponsor

Cycle Pharmaceuticals Ltd.

Collaborators

[object Object]